| ²é¿´: 801 | »Ø¸´: 7 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
caohoupingľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇâÂÈàçàºEP7.6ÖÊÁ¿±ê×¼
|
||
| ÇâÂÈàçàºEP7.6ÖÊÁ¿±ê×¼£¬ÇóÖú£¡Ð»Ð»¸÷λÁË |
» ²ÂÄãϲ»¶
·ÇÈ«ÈÕÖÆ¹«¹²¹ÜÀíÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ҩѧ298·Ö-Ò»Ö¾Ô¸Öйúº£Ñó´óѧ-Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ270È˻ظ´
¡¾#ÉϺ£µ÷¼Á¼±Â¼#¡¿ÄܽÓÊÜ985ÁªºÏÅàÑøµÄËÙÀ´£¡´øÄã·¢Ò»ÇøÎÄÕ£¡
ÒѾÓÐ4È˻ظ´
¡¾ÉϺ£µ÷¼Á¡¿985ÁªºÏÅàÑø£¡±ð´í¹ýÄÜËÍÄãÈ¥µ¤Âó/½»´ó/ͬ¼Ã/ÖпÆÔºµÄÉñÏɵ¼Ê¦£¡
ÒѾÓÐ0È˻ظ´
¡¾µ÷¼ÁÉϰ¶¡¿985ÁªºÏÅàÑø£¡1007/1055/08/07µÈ£¬²»ÏÞרҵ£¬ÏëÁªÅàµÄËÙÀ´£¡
ÒѾÓÐ3È˻ظ´
¡¾ÉϺ£µ÷¼Á¡¿985ÁªºÏÅàÑø£¡±ð´í¹ýÄÜËÍÄãÈ¥µ¤Âó/½»´ó/ͬ¼Ã/ÖпÆÔºµÄÉñÏɵ¼Ê¦£¡
ÒѾÓÐ14È˻ظ´
¡¾#ÉϺ£µ÷¼Á¼±Â¼#¡¿ÄܽÓÊÜ985ÁªºÏÅàÑøµÄËÙÀ´£¡´øÄã·¢Ò»ÇøÎÄÕ£¡
ÒѾÓÐ5È˻ظ´
caohouping
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 4673.1
- ºì»¨: 12
- Ìû×Ó: 991
- ÔÚÏß: 418.6Сʱ
- ³æºÅ: 1115654
- ×¢²á: 2010-10-07
- ÐÔ±ð: GG
- רҵ: »·¾³Î¢ÉúÎïѧ
|
SUPPLEMENT 7.6 Related substances: in line with the general monograph Substances for pharmaceutical use (2034), an explicit acceptance criterion for unspecified impurities has been introduced; in addition, relative retentions of specified impurities are now given, and a peak identification CRS has been introduced to allow the identification of specified impurities. SUPPLEMENT 7.4 Content: lower limit updated to reflect change in assay method. Assay: titration replaced by LC. SUPPLEMENT 6.4 Characters: the substance shows polymorphism. PUBLICATION 6.0 Identification: IR spectra might show differences that disappear after recrystallisation: corresponding statement added. |
5Â¥2013-07-08 17:57:03
so0325
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 56 (³õÖÐÉú)
- ½ð±Ò: 1734.4
- ºì»¨: 3
- Ìû×Ó: 290
- ÔÚÏß: 120.8Сʱ
- ³æºÅ: 401234
- ×¢²á: 2007-06-13
- ÐÔ±ð: MM
- רҵ: ºÏ³ÉÒ©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ºÓ±ßµÄ«Î: ½ð±Ò+1, ¸ÐлÄãµÄ»ØÌû½»Á÷~ 2013-07-08 15:22:52
ºÓ±ßµÄ«Î: »ØÌûÖö¥ 2013-07-08 15:22:57
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ºÓ±ßµÄ«Î: ½ð±Ò+1, ¸ÐлÄãµÄ»ØÌû½»Á÷~ 2013-07-08 15:22:52
ºÓ±ßµÄ«Î: »ØÌûÖö¥ 2013-07-08 15:22:57
| BP2013µÄ¿ÉÒÔ²»£¬»ù±¾ÊÇÕÕ×ÅEP°ÇÏÂÀ´µÄ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ÇâÂÈàçàº-BP2013.rar
2013-07-08 14:20:38, 120.74 K
2Â¥2013-07-08 14:20:51
caohouping
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 4673.1
- ºì»¨: 12
- Ìû×Ó: 991
- ÔÚÏß: 418.6Сʱ
- ³æºÅ: 1115654
- ×¢²á: 2010-10-07
- ÐÔ±ð: GG
- רҵ: »·¾³Î¢ÉúÎïѧ
4Â¥2013-07-08 17:55:52
caohouping
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 16 (СѧÉú)
- ½ð±Ò: 4673.1
- ºì»¨: 12
- Ìû×Ó: 991
- ÔÚÏß: 418.6Сʱ
- ³æºÅ: 1115654
- ×¢²á: 2010-10-07
- ÐÔ±ð: GG
- רҵ: »·¾³Î¢ÉúÎïѧ
|
New for 2013 Legally effective from 1 January 2013 41 new BP monographs 40 new European Pharmacopoeia monographs 619 amended monographs 6 new and 1 amended Infrared Reference Spectra European Pharmacopoeia 7th edition material up to and including Supplement 7.5 Free in-year updates in January, April and July to harmonise with the European Pharmacopoeia |
6Â¥2013-07-08 17:57:57














»Ø¸´´ËÂ¥